THE GUSTAVE ROUSSY Institute of Oncology is looking to recruit young doctors, pharmacists and engineers in France, Europe and the rest of the world, offering three-year research contracts to work with the institute’s researchers toward the presentation of a doctoral thesis in sciences.
In his new book, “No More Tears: The Dark Secrets of Johnson & Johnson,” Gardiner Harris, who was previously the public health and pharmaceutical business reporter for The New York Times, talks about the history of the overuse of red blood cell growth factors in oncology.
